Cargando…
WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192164/ http://dx.doi.org/10.1016/S1569-1993(21)00994-2 |
_version_ | 1783706000786718720 |
---|---|
author | Richards, K. Geoghegan, S. Butler, M. Shafi, N. Watson, D. |
author_facet | Richards, K. Geoghegan, S. Butler, M. Shafi, N. Watson, D. |
author_sort | Richards, K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8192164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Cystic Fibrosis Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81921642021-06-11 WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic Richards, K. Geoghegan, S. Butler, M. Shafi, N. Watson, D. J Cyst Fibros Workshops European Cystic Fibrosis Society. 2021 2021-06-11 /pmc/articles/PMC8192164/ http://dx.doi.org/10.1016/S1569-1993(21)00994-2 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Workshops Richards, K. Geoghegan, S. Butler, M. Shafi, N. Watson, D. WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title | WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title_full | WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title_fullStr | WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title_full_unstemmed | WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title_short | WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic |
title_sort | ws14.2 potential factors influencing reduced requirements for intravenous antibiotics during the covid-19 pandemic |
topic | Workshops |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192164/ http://dx.doi.org/10.1016/S1569-1993(21)00994-2 |
work_keys_str_mv | AT richardsk ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic AT geoghegans ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic AT butlerm ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic AT shafin ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic AT watsond ws142potentialfactorsinfluencingreducedrequirementsforintravenousantibioticsduringthecovid19pandemic |